Compare $KEQU vs $NRXS | Chartloom

Compare

$KEQU vs $NRXS

Kewaunee Scientific Corp · Neuraxis Inc

KEQU

Kewaunee Scientific Corp

NRXS

Neuraxis Inc

Compare $KEQU vs $NRXS

Comparing Kewaunee Scientific Corp and Neuraxis Inc

KEQUKewaunee Scientific Corp

NRXSNeuraxis Inc

KEQUKewaunee Scientific Corp

Market cap

$97M

P/E (TTM)

11.99x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.3%

YTD performance

-9.9%

52W performance

-21.2%

FCF yield

11.2%

NRXSNeuraxis Inc

Market cap

$86M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.62x

Rev growth (TTM)

65.2%

YTD performance

55.4%

52W performance

121.4%

FCF yield

-6.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KEQU

NRXS

Detailed metrics comparison

KEQU

Kewaunee Scientific Corp

NRXS

Neuraxis Inc

Market Cap

KEQU$97M

NRXS$86M

Enterprise Value

KEQU$135M

NRXS$78M

Price

KEQU$33.79

NRXS$6.93

P/E Ratio

KEQU11.99x

NRXSN/A

P/S Ratio

KEQU0.35x

NRXS16.14x

EV/Sales

KEQU0.49x

NRXS14.58x

EV/EBITDA

KEQU6.29x

NRXS0.00x

P/B Ratio

KEQU1.32x

NRXS13.26x

P/FCF Ratio

KEQU8.91x

NRXSN/A

EV/FCF

KEQU12.37x

NRXS-13.52x

PEG Ratio

KEQUN/A

NRXSN/A

Forward P/E (NTM)

KEQUN/A

NRXSN/A

Forward P/S (NTM)

KEQUN/A

NRXS6.62x

Revenue (TTM)

KEQU$277M

NRXS$5M

Revenue Growth (YoY)

KEQU5.3%

NRXS65.2%

Forward Rev Growth

KEQU0.0%

NRXS124.9%

Gross Margin (TTM)

KEQU28.6%

NRXS85.6%

Operating Margin (TTM)

KEQU5.4%

NRXS0.0%

EBITDA Margin (TTM)

KEQU7.7%

NRXS-143.1%

Net Margin (TTM)

KEQU3.0%

NRXS-159.0%

FCF Margin (TTM)

KEQU3.9%

NRXS-107.8%

Net Income (TTM)

KEQU$8M

NRXS$-8M

FCF (TTM)

KEQU$11M

NRXS$-6M

EPS (TTM)

KEQU$2.82

NRXS-$0.70

ROE (TTM)

KEQU11.3%

NRXS-16907.0%

ROA (TTM)

KEQU4.6%

NRXS-9933.0%

ROIC (TTM)

KEQU6.6%

NRXS-16465.0%

Cash

KEQU$8M

NRXS$8M

Debt

KEQU$46M

NRXS$43K

Net Cash/Debt

KEQU$-38M

NRXS$8M

Current Ratio (TTM)

KEQU2.20x

NRXS3.04x

Quick Ratio (TTM)

KEQU1.45x

NRXS2.83x

Debt/Equity (TTM)

KEQU0.61x

NRXS0.01x

Debt/Assets (TTM)

KEQU0.0%

NRXS0.0%

Interest Coverage (TTM)

KEQUN/A

NRXSN/A

Net Debt/EBITDA (TTM)

KEQU0.00x

NRXS0.00x

Beta

KEQU0.88

NRXS1.40

52W Performance

KEQU-21.2%

NRXS121.4%

YTD Performance

KEQU-9.9%

NRXS55.4%

% from 52W High

KEQU-27.4%

NRXS-25.7%

% from 52W Low

KEQU5.6%

NRXS213.6%

Asset Turnover (TTM)

KEQU1.54x

NRXS0.69x

FCF Yield (TTM)

KEQU11.2%

NRXS-6.7%

Earnings Yield (TTM)

KEQU8.5%

NRXS-9.9%

Dividend Yield (TTM)

KEQUN/A

NRXSN/A

Rule of 40

KEQU9.3

NRXS-42.6

EV/GP/RG

KEQUN/A

NRXS0.12

Ticker research

View KEQU research View NRXS research

Metric	KEQU Kewaunee Scientific Corp	NRXS Neuraxis Inc
Market & Valuation
Market Cap	$97M	$86M
Enterprise Value	$135M	$78M
Price	$33.79	$6.93
P/E Ratio	11.99x	N/A
P/S Ratio	0.35x	16.14x
EV/Sales	0.49x	14.58x
EV/EBITDA	6.29x	0.00x
P/B Ratio	1.32x	13.26x
P/FCF Ratio	8.91x	N/A
EV/FCF	12.37x	-13.52x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.62x
Revenue & Growth
Revenue (TTM)	$277M	$5M
Revenue Growth (YoY)	5.3%	65.2%
Forward Rev Growth	0.0%	124.9%
Profitability
Gross Margin (TTM)	28.6%	85.6%
Operating Margin (TTM)	5.4%	0.0%
EBITDA Margin (TTM)	7.7%	-143.1%
Net Margin (TTM)	3.0%	-159.0%
FCF Margin (TTM)	3.9%	-107.8%
Net Income (TTM)	$8M	$-8M
FCF (TTM)	$11M	$-6M
EPS (TTM)	$2.82	-$0.70
ROE (TTM)	11.3%	-16907.0%
ROA (TTM)	4.6%	-9933.0%
ROIC (TTM)	6.6%	-16465.0%
Financial Health
Cash	$8M	$8M
Debt	$46M	$43K
Net Cash/Debt	$-38M	$8M
Current Ratio (TTM)	2.20x	3.04x
Quick Ratio (TTM)	1.45x	2.83x
Debt/Equity (TTM)	0.61x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	1.40
52W Performance	-21.2%	121.4%
YTD Performance	-9.9%	55.4%
% from 52W High	-27.4%	-25.7%
% from 52W Low	5.6%	213.6%
Efficiency & Yields
Asset Turnover (TTM)	1.54x	0.69x
FCF Yield (TTM)	11.2%	-6.7%
Earnings Yield (TTM)	8.5%	-9.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	9.3	-42.6
EV/GP/RG	N/A	0.12
Ticker research	View KEQU research	View NRXS research

Valuation

P/E Ratio

KEQU

11.99x

P/S Ratio

KEQU

0.35x

NRXS

16.14x

EV/FCF

NRXS

-13.52x

KEQU

12.37x

Growth & revenue

Revenue Growth TTM

NRXS

65.2%

KEQU

5.3%

Forward Revenue Growth

NRXS

124.9%

KEQU

0.0%

Profitability & performance

Gross Margin

NRXS

85.6%

KEQU

28.6%

ROE

KEQU

11.3%

NRXS

-16907.0%

FCF Yield %

KEQU

11.2%

NRXS

-6.7%

52-Week Performance

NRXS

121.4%

KEQU

-21.2%

Detailed metrics comparison

KEQU

Kewaunee Scientific Corp

NRXS

Neuraxis Inc

Market Cap

KEQU$97M

NRXS$86M

Enterprise Value

KEQU$135M

NRXS$78M

Price

KEQU$33.79

NRXS$6.93

P/E Ratio

KEQU11.99x

NRXSN/A

P/S Ratio

KEQU0.35x

NRXS16.14x

EV/Sales

KEQU0.49x

NRXS14.58x

EV/EBITDA

KEQU6.29x

NRXS0.00x

P/B Ratio

KEQU1.32x

NRXS13.26x

P/FCF Ratio

KEQU8.91x

NRXSN/A

EV/FCF

KEQU12.37x

NRXS-13.52x

PEG Ratio

KEQUN/A

NRXSN/A

Forward P/E (NTM)

KEQUN/A

NRXSN/A

Forward P/S (NTM)

KEQUN/A

NRXS6.62x

Revenue (TTM)

KEQU$277M

NRXS$5M

Revenue Growth (YoY)

KEQU5.3%

NRXS65.2%

Forward Rev Growth

KEQU0.0%

NRXS124.9%

Gross Margin (TTM)

KEQU28.6%

NRXS85.6%

Operating Margin (TTM)

KEQU5.4%

NRXS0.0%

EBITDA Margin (TTM)

KEQU7.7%

NRXS-143.1%

Net Margin (TTM)

KEQU3.0%

NRXS-159.0%

FCF Margin (TTM)

KEQU3.9%

NRXS-107.8%

Net Income (TTM)

KEQU$8M

NRXS$-8M

FCF (TTM)

KEQU$11M

NRXS$-6M

EPS (TTM)

KEQU$2.82

NRXS-$0.70

ROE (TTM)

KEQU11.3%

NRXS-16907.0%

ROA (TTM)

KEQU4.6%

NRXS-9933.0%

ROIC (TTM)

KEQU6.6%

NRXS-16465.0%

Cash

KEQU$8M

NRXS$8M

Debt

KEQU$46M

NRXS$43K

Net Cash/Debt

KEQU$-38M

NRXS$8M

Current Ratio (TTM)

KEQU2.20x

NRXS3.04x

Quick Ratio (TTM)

KEQU1.45x

NRXS2.83x

Debt/Equity (TTM)

KEQU0.61x

NRXS0.01x

Debt/Assets (TTM)

KEQU0.0%

NRXS0.0%

Interest Coverage (TTM)

KEQUN/A

NRXSN/A

Net Debt/EBITDA (TTM)

KEQU0.00x

NRXS0.00x

Beta

KEQU0.88

NRXS1.40

52W Performance

KEQU-21.2%

NRXS121.4%

YTD Performance

KEQU-9.9%

NRXS55.4%

% from 52W High

KEQU-27.4%

NRXS-25.7%

% from 52W Low

KEQU5.6%

NRXS213.6%

Asset Turnover (TTM)

KEQU1.54x

NRXS0.69x

FCF Yield (TTM)

KEQU11.2%

NRXS-6.7%

Earnings Yield (TTM)

KEQU8.5%

NRXS-9.9%

Dividend Yield (TTM)

KEQUN/A

NRXSN/A

Rule of 40

KEQU9.3

NRXS-42.6

EV/GP/RG

KEQUN/A

NRXS0.12

Ticker research

View KEQU research View NRXS research

Metric	KEQU Kewaunee Scientific Corp	NRXS Neuraxis Inc
Market & Valuation
Market Cap	$97M	$86M
Enterprise Value	$135M	$78M
Price	$33.79	$6.93
P/E Ratio	11.99x	N/A
P/S Ratio	0.35x	16.14x
EV/Sales	0.49x	14.58x
EV/EBITDA	6.29x	0.00x
P/B Ratio	1.32x	13.26x
P/FCF Ratio	8.91x	N/A
EV/FCF	12.37x	-13.52x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.62x
Revenue & Growth
Revenue (TTM)	$277M	$5M
Revenue Growth (YoY)	5.3%	65.2%
Forward Rev Growth	0.0%	124.9%
Profitability
Gross Margin (TTM)	28.6%	85.6%
Operating Margin (TTM)	5.4%	0.0%
EBITDA Margin (TTM)	7.7%	-143.1%
Net Margin (TTM)	3.0%	-159.0%
FCF Margin (TTM)	3.9%	-107.8%
Net Income (TTM)	$8M	$-8M
FCF (TTM)	$11M	$-6M
EPS (TTM)	$2.82	-$0.70
ROE (TTM)	11.3%	-16907.0%
ROA (TTM)	4.6%	-9933.0%
ROIC (TTM)	6.6%	-16465.0%
Financial Health
Cash	$8M	$8M
Debt	$46M	$43K
Net Cash/Debt	$-38M	$8M
Current Ratio (TTM)	2.20x	3.04x
Quick Ratio (TTM)	1.45x	2.83x
Debt/Equity (TTM)	0.61x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	1.40
52W Performance	-21.2%	121.4%
YTD Performance	-9.9%	55.4%
% from 52W High	-27.4%	-25.7%
% from 52W Low	5.6%	213.6%
Efficiency & Yields
Asset Turnover (TTM)	1.54x	0.69x
FCF Yield (TTM)	11.2%	-6.7%
Earnings Yield (TTM)	8.5%	-9.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	9.3	-42.6
EV/GP/RG	N/A	0.12
Ticker research	View KEQU research	View NRXS research